Clinical Trials Logo

Dynapenia clinical trials

View clinical trials related to Dynapenia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03708354 Withdrawn - Clinical trials for Postmenopausal Women

Tocotrienols for Skeletal Muscle Health

VitE-muscle
Start date: April 15, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Sarcopenia, defined as a reduction in muscle mass and strength, is a major health concern for postmenopausal women. Evidence suggests that lowering inflammation levels is an important strategy to help mitigate age-related muscle dysfunction and loss. In this pilot study, the investigators will study a tocotrienol (vitamin-E isomer) intervention for feasibility and quantify its effects on postmenopausal women with low muscle strength. A double blind, placebo controlled trial will be conducted on fifty-two qualified subjects. The participants will be assigned to placebo or tocotrienols for 24 weeks. All participants will receive an Omron Alvita Optimized Pedometer. The investigators will measure muscular endurance, strength, and size and gut microbiome profiles at 0, 12, and 24 weeks. In addition, the investigators will measure serum and muscle inflammatory levels at 0 and 24 weeks. All data will be analyzed statistically at p<0.05.